News

Site Search:

    

 Fri, 21 Nov 2008 14:58:52 -- Updated: Fri, 21 Nov 2008 06:58:52
Danish drugmaker Novo Nordisk has unveiled an ambitious plan to build an insulin plant in China, tapping into a major new market for diabetes treatments. Full story
Top Stories
•  中国生物产业基金设立

北大未名生物工程集团与长沙国家生物产业基地日前正式签署战略合作协议,协议商定,双方将与省内多家投资、金融机构共同发起设立“中国生物产业基金”,推动湖南乃至全国生物产业的发展。

•  耶鲁大学推出新的物理和工程生物学博士学位

耶鲁大学将提供一个新的博士学位计划在物理和工程生物学,综合历来是独立研究的两个学科。这个物理工程生物综合研究生项目( IGPPEB...

•  拜尔承诺投资150万欧元在华发展血友病综合理疗中心

中国领先的医药公司、血友病治疗领域的全球领导者拜耳先灵医药 (Bayer Schering Pharmaceuticals)...


     






深圳微芯生物科技获2008德勤中国高成长50强

作为国内创新药研发的代表企业,深圳微芯生物科技有限公司以三年增长率650%的骄人业绩荣膺"2008德勤中国高科技、高成长50强"殊荣,列第24位。微芯生物公司总裁/首席科学官鲁先平...

China to Emerge as Fourth...

China is expected to become the world’s fourth largest western drug consumer by 2012 as aging...

Leading Japanese CRO CMIC...

Clinical Trial Technology Company Broadens Asia-Pac Presence through Partnership with Tokyo-Based...

Roche Expanding In Shanghai;...

Roche has broken ground on an expansion of its facilities at its site in Shanghai’s Zhangjiang...

BioCurex Incorporates Chinese...

BioCurex Inc. has incorporated a fully-owned subsidiary, BioCurex China, in Shanghai. This followed...


 Most Popular »
Medical firm doing very well in China

Global healthcare firm, International SOS, will focus more on China as its client base in the...

无锡生物医药研发服务外包区开园

11月9日上午10点,无锡生物医药研发服务外包区(B-Park)开园暨十大研发中心揭牌仪式在马山梅梁西路隆重举行,首批十大研发中心正式入驻外包区。

西宁市生物科技园区将大变身一园变四园

今后,位于西宁市城北区的生物科技产业园区将大变身,不仅用地规模增大十几平方公里,而且也由原先的一园变为四园。变身后的西宁经济技术开发区高新技术产业园区,由生物产业园、装备制造园、大学科技园和农业科技园...

China, the FDA, and the Widening Gap in Consumer Safety

The pharmaceutical manufacturing market is clearly being taken over by low-cost Chinese producers. ...

NeoStem Signs Definitive Agreement to Acquire Controlling...

NeoStem, Inc., which is pioneering the pre-disease collection, processing and long-term storage of...

    


© 2005-2008 China Bionews Online
All Rights Reserved. 

Powered by: PHPCow.com